Shalini Reshmi Selected Research

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)

1/2017	Genomic analysis of adult B-ALL identifies potential markers of shorter survival.
2/2016	Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia.
9/2014	Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.
4/2012	Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia: a Children's Oncology Group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shalini Reshmi Research Topics

Disease

4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 04/2012
2	Philadelphia Chromosome 02/2016 - 09/2014
1	Neuroblastoma 10/2021
1	Chromosome Aberrations (Chromosome Abnormalities) 10/2021
1	Hypersensitivity (Allergy) 02/2016
1	Polycythemia (Erythrocytosis) 02/2016
1	Leukemia 09/2014
1	Limb-girdle muscular dystrophy type 2A 05/2013
1	Residual Neoplasm 04/2012
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2010
1	Amyloid Plaque 07/2010

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 10/2021 - 01/2017
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 02/2016
1	Erythropoietin FDA Link 02/2016
1	Tyrosine (L-Tyrosine)FDA Link 02/2016
1	Transcription Factors (Transcription Factor)IBA 09/2014
1	Phosphotransferases (Kinase)IBA 09/2014
1	Tyrosine Kinase InhibitorsIBA 09/2014
1	MicroRNAs (MicroRNA)IBA 05/2013
1	Messenger RNA (mRNA)IBA 04/2012
1	DystrophinIBA 09/2010
1	DysferlinIBA 07/2010

Therapy/Procedure

1	Therapeutics 09/2014